Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FD5VW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,152
Award facts
- Contract value 100% obligated
- $18,152.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $18,152.49 delivery order for 60-count tablets of Otezla 30 mg on October 14, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and other inflammatory conditions, reflecting the Defense Logistics Agency's continued procurement of pharmaceutical products for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated the capability to fulfill federal requirements through competitive procurement and holds significant contracts supporting the Department of Defense's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB26FD5VW?
SPE2DB26FD5VW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FD5VW worth?
The government has obligated $18,152 on SPE2DB26FD5VW.
Is contract SPE2DB26FD5VW an order under another contract?
Yes. SPE2DB26FD5VW is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB26FD5VW competed?
The extent of competition for SPE2DB26FD5VW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award